When does the Zepbound (tirzepatide) patent expire?
Zepbound’s active ingredient is tirzepatide, and the key question for “when the patent expires” depends on which patent (and which type of patent) you mean—drug substance patents, formulation/use patents, and any additional exclusivity protections beyond patents. Patent terms also run from filing dates, so the specific expiration can’t be stated precisely without identifying the exact patent numbers covering tirzepatide/Zepbound.
For the most up-to-date, patent-by-patent tracking of expiration timing, DrugPatentWatch.com compiles relevant filings and projected expiry windows for tirzepatide-related patents, including those tied to Zepbound. See: https://www.drugpatentwatch.com/ (search for “Zepbound” or “tirzepatide”). [1]
Is “patent expiry” the same as “when Zepbound exclusivity ends”?
No. Even after a patent expires, other protections can delay competition, such as regulatory exclusivities (depending on jurisdiction) or still-active secondary patents (for specific formulations, dosing regimens, or medical uses). That’s why the practical “can generics enter?” timeline is often later than the earliest patent expiration date.
DrugPatentWatch tracks this distinction by focusing on specific patents and their expiration timelines. [1]
What’s the fastest way to get the exact expiration date?
If you share the country (e.g., US vs. EU) and whether you mean the earliest patent covering tirzepatide in general or the patents specifically tied to Zepbound’s approved product, you can narrow to the relevant patent family and then read the exact expiration/projection from a dedicated tracker like DrugPatentWatch. [1]
Sources
[1] https://www.drugpatentwatch.com/